3704
|
(S)-ErSO
|
Inactive enantiomer of ErSO |
€180.00 |
3718
|
AB-680 ammonium salt
|
CD73 inhibitor |
Inquire |
3696
|
ABBV-075
|
Highly potent and orally bioavailable BET bromodomain (BRD) inhibitor |
€110.00 |
3698
|
AC-5216
|
Selective translocator protein (TSPO) ligand |
€90.00 |
3714
|
BCL-201 dihydrochloride
|
BH3-mimetic inhibitor of BCL-2 protein |
Inquire |
3471
|
BI-3406
|
Inhibitor of KRAS/Son of Sevenless 1 (SOS1) interaction |
Inquire |
3697
|
Binimetinib
|
Potent, selective, non-ATP-competitive and orally available allosteric inhibitor of MEK1/2 |
€60.00 |
3716
|
BMS-986158
|
BET bromodomain (BRD) inhibitor |
Inquire |
3715
|
E-7386
|
CBP/beta-catenin modulator |
Inquire |
3594
|
ErSO
|
Orally bioavailable a-UPR activator |
€180.00 |
3717
|
GSK2256098
|
FAK inhibitor |
Inquire |
3721
|
JAB-3068
|
SHP2 inhibitor |
€240.00 |
3683
|
L6H21
|
Specific MD-2 inhibitor |
€120.00 |
3724
|
M-3258
|
Selective inhibitor of LMP7 subunit of the immunoproteasome |
Inquire |
3713
|
MIK665
|
BH3-Groove binding Mcl-1 inhibitor |
Inquire |
3599
|
MINA53 inhibitor compound 10
|
First-in-class, potent and selective MINA53 inhibitor |
€120.00 |
3681
|
MS023 dihydrochloride
|
Potent, cell-active, and Type I selective PRMT inhibitor |
€90.00 |
3480
|
PY-60
|
Specific YAP activator targeting ANXA2 |
€150.00 |
3685
|
Rilpivirine
|
Highly active and orally bioavailable NNRT inhibitor (HIV-1) |
€95.00 |
3723
|
S63845
|
BH3-Groove binding Mcl-1 inhibitor |
Inquire |
3645
|
Sotalol hydrochloride
|
Orally bioavailable, competitive β-adrenoceptor antagonist |
€60.00 |
3673
|
STING activator C53
|
Highly potent STING activator |
€120.00 |
3602
|
tBT-HBT
|
Noncovalent, tight-binding inhibitor of HhC cholesterolysis |
€120.00 |
3561
|
THZ1 dihydrochloride
|
Covalent CDK7 inhibitor |
€110.00 |
3595
|
Usmarapride
|
Potent, selective and orally bioavailable 5-HT4 receptor partial agonist |
€180.00 |
3722
|
Valemetostat
|
Inhibitor of Histone Lysine Methyltransferase EZH1/2 |
€160.00 |